Organovo

$0.2851
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0015 (-0.52%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Organovo and other stocks, options, ETFs, and crypto commission-free!

About ONVO

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. Read More The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

Employees
61
Headquarters
San Diego, California
Founded
2012
Market Cap
37.34M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
494.90K
High Today
$0.2949
Low Today
$0.2851
Open Price
$0.29
Volume
188.01K
52 Week High
$1.27
52 Week Low
$0.2196

Collections

ONVO Earnings

-$0.09
-$0.08
-$0.06
-$0.05
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
Actual
Expected Nov 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.